Back

Defibrillation success after subcutaneous implantable cardioverter-defibrillator generator replacement is not affected by impedance increase.

24 April 2021 (19:20 - 20:20)
Organised by:
Congress Presentation Part of: News from ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2021

About the speaker

Photo
Mrs Willeke van der Stuijt

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry
Professor P. Lambiase (London, GB)
Abstract Slides Video
Presentation thumbnail
Accelerometry-assessed physical behaviour and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: a systematic review.
Mr M. Kolk (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity matched case-control study
Doctor V. Bianchi (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.
Doctor A. Bodin (Chambray Les Tours, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of subcutaneous implantable cardioverter-defibrillator appropriate and inappropriate shocks
Doctor L. Oliveira (Ponta Delgada, PT)
Abstract Slides Video

Access the full session

Session thumbnail
News from ICD therapy

The Event

Event poster

EHRA 2021

24 April 2021 19:20 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources